RPTX: Repare Therapeutics Inc Company Profile & Statistics

About

Repare Therapeutics Inc. is an oncology company. It utilizes genome-wide, CRISPR-enabled SNIPRx(R) platform to discover and develop targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company's product pipeline includes RP-3500, which is in clinical stage. Repare Therapeutics Inc. is based in St-Laurent, Canada.

Info & Links

CEO

Lloyd M. Segal

Headquarters

7171 Frederick-Banting, Building 2, Suite 270
St-Laurent, A8 H4S 1Z9, CANADA

Auditor

Ernst & Young LLP

Share holders

Employees

179

Repare Therapeutics Inc Statistics

Valuation Measures

Market Capitalization²

53.99M

Enterprise Value

-26.55M

Enterprise Value/EBITDA(ttm)

0.27

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

1.10

Price to Book(mrq)

0.43

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

75.00%

Operating Margin(ttm)

-99.76%

Profit Margin(ttm)

-857.64%

Return on Equity(ttm)

-40.87%

Return on Invested Capital(ttm)

-44.28%

Return on Assets(ttm)

-35.07%

Income Statement

Revenue(ttm)

66.52M

Revenue Per Share(ttm)

1.56

Gross Profit(ttm)

66.52M

EBITDA(ttm)³

-97.72M

Net Income Available to Common(ttm)

-84.05M

Diluted EPS(ttm)

-2.00

Share Statistics

Beta (5Y Monthly)

0.71

52-Week Change

-75.99%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

42.51M

Dividend Yield

0.00%

Float⁴

33.33M

% Held by Insiders

21.60%

% Held by Institutions

85.09%

Balance Sheet

Total Cash(mrq)

179.43M

Total Cash Per Share(mrq)

4.22

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.45%

Quick Ratio(mrq)

6.45%

Book Value Per Share(mrq)

4.12

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.16

Free Cash Flow(ytd)

-49.12M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

RPTX

Repare Therapeutics Inc

Repare Therapeutics Inc Profile